WILLIAMS AND JENSEN, PLLC for PFIZER
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Senator Kennedy cancer legislation; Prescription drug advertising; and Federal preemption for prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ANDERSON | — |
| JENNY DIJAMES | — |
| DENIS DWYER | — |
| JACK STEVEN HART | — |
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
| PATRICK PETTEY | — |
| ANTHONY J RODA | — |
| JOYCE A ROGERS | — |
Taxation/Internal Revenue Code TAX
Tax issues affecting the pharmaceutical industry including international tax. H.R. 4213, revenue proposals on international tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Labor Issues/Antitrust/Workplace LBR
Wyeth acquisition
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ANDERSON | — |
| JENNY DIJAMES | — |
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| KARINA LYNCH | — |
| PATRICK PETTEY | — |
| ANTHONY J RODA | — |
| JOYCE A ROGERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.